A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles

Document Type : Short Communication

Authors

1 Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

2 Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

3 Department of Medical Parasitology and Mycology, School of Medicine, Babol University of Medical Sciences, Babol, Iran

10.32598/CMM.2023.1368

Abstract

Background and Purpose: Scedosporium species are ubiquitous environmental fungi,
which are considered emerging agents that trigger disease in humans and animals. The
present study aimed to determine Scedosporium dehoogii strain isolated from paddy field soil samples using semi-selective media and evaluate its antifungal susceptibility profile.
Materials and Methods: Three paddy field soil samples were collected during an
investigation for the isolation of Scedosporium species in Mazandaran province, Iran.
Morphological and molecular analyses based on ITS-rDNA sequencing were performed. Furthermore, in vitro antifungal susceptibility testing for conventional drugs and novel imidazole (luliconazole) was performed based on Clinical and Laboratory Standards Institute M38-A3 guidelines.
Results: In this study, S. dehoogii was isolated from the soil in paddy fields. Based on
the results, itraconazole and luliconazole showed the least and most antifungal activity
against this isolate, respectively.
Conclusion: Based on the findings, molecular identification was essential for
distinguishing the species of S. dehoogii. Remarkably, luliconazole showed potent activity against this strain.


 

Keywords


Introduction

Scedosporium species are ubiquitous and emerging opportunistic mold pathogens [ 1 ]. They cause invasive fungal infections in otherwise healthy individuals and trigger a broad spectrum of clinical manifestations, including invasive pulmonary disease, mycetoma, osteomyelitis, keratitis, brain abscesses, and meningitis [ 2 , 3 ]. Although S. apiospermum, S. boydii, S. dehoogii, S. minutisporum, and S. aurantiacum are the main etiological agents of scedosporiosis, some rare species have been reported as etiological agents of this infection [ 1 , 2 ].

Scedosporium species show reduced susceptibility to all conventional antifungal drugs [ 4 ].

Accurate knowledge of the ecological niches and potential reservoirs of these species has shown that they are more common in human-impacted and polluted environments, such as agricultural soil, public parks, polluted ponds, compost, sewage, polluted water, and effluents of wastewater treatment plants [ 5 - 8 ]. In addition, hydrocarbon-contaminated soil was reported as a habitat of these fungi[ 1 ]. The current study aimed to report the first isolation of S. dehoogii from paddy field soil samples and its antifungal susceptibility profiles. Furthermore, the physicochemical parameters of the soil sample were evaluated.

Materials and Methods

Sampling, fungal isolation, and identification

Three soil samples were collected from 5-10 cm depth of different areas in a paddy field (36.883331, 50.736441) of Ketalem and Sadat Shahr, Ramsar county in Mazandaran province, Iran. The samples were examined in terms of the detection and isolation of Scedosporium species. For this purpose, 8 gr soil samples were suspended in 10 ml of sterile distilled water solution, vortexed vigorously and thoroughly, and allowed to settle down. Subsequently, 200 µL of the suspension was inoculated into two semi-selective media, namely Dichloran Rose-Bengal Chloram-phenicol agar supplemented with 10 µg/mL Benomyl [ 9 ] and Scedo-Select III [ 10 ], for up to 2 weeks at 35°C to maximize the selective yield.

Results

The mimicking Sceodosporium species were able to grow in the semi-selective media and were identified by macroscopic and microscopic features followed by molecular identification as previously described [ 9 , 10 ]. Eventually, one Sceodosporium species was isolated from two semi-selective media. Morphological features were distinguished on Potato Dextrose Agar (PDA, CONDALAB, Spain) at 35 °C for 7 days.

Colony morphology characteristics of S. dehoogii on different media were shown in Figure 1 A-C. The colonies grew and their diameter reached 36 mm after 7 days at 35 °C; they were dense, grayish-white to pale gray, wooly to cottony, whitish irregular border, and yellowish to light-brown reverse (Figure 1B). Microscopic features were studied using lactophenol aniline blue staining (Figure 1 D-F). Solitary conidiogenous cells were usually subhyaline, smooth with thick-wall, generally cylindrical, and ellipsoidal or obovoid conidia (Figure 1 D-E). Synnematous conidiophores were observed to be terminated in a slimy head of conidia (Figure 1 F). The teleomorph form was not observed in these media.

Figure 1.Morphology and microscopic characteristics of Scedosporium dehoogii. A) Colony growing on Sabouraud Dextrose Agar B) Potato Dextrose Agar C) Dichloran rose-bengal chloramphenicol agar supplemented with benomyl (10 µg/mL) after 7 days at 35 °C D and E) Conidiogenous cells and cylindrical and sessile conidia F) Synnematous conidiophores were observed to be terminated in a slimy head of conidia.

In addition, the final identification of this strain was performed through DNA gene sequencing. Briefly, total genomic DNA was extracted from fresh and pure culture using the phenol-chloroform method [ 11 ]. The polymerase chain reaction was operated using internal transcribed spacer1 (ITS1) and ITS4 primers for the ITS-rDNA regions. Fungal DNA was amplified following a procedure for the initial DNA denaturation stage at 94 °C for 5 min, 35 cycles of DNA denaturation stage at 94 °C for 1 min, annealing stage at 52 °C for 1 min, extension stage at 72 °C for 2 min, and final extension at 72 °C for 5 min [ 9 ].

The obtained sequence was adjusted using Lasergene SeqMan software (version 9.0.5) and compared with GenBank (), ISHAM ITS barcoding database (), and Mycobank (). The DNA sequence of the ITS-rDNA region (OP363344) showed 99.82% similarity with the ex-type isolate of S. dehoogii (KX664394.1).

Phylogenetic analysis

Sequences of the ITS-rDNA region of obtained strain and reference strains, including the type strain of S. dehoogii, were aligned with the MEGA software (version 11). Maximum likelihood analysis was performed with the Kimura 2-parameter model and 1000 bootstrapping replications (Figure 2). In this phylogenetic tree, 14 different type strains of 8 species in the Scedosporium clade were used. Furthermore, 10 strains of S. dehoogii from different countries (Belgium, Italy, Chile, Mexico, Spain, Netherlands, Chile, China, Australia, and Malaysia) with soil sources were applied. Lomentospora prolificans CBS 116908 was used as the outgroup.

Figure 2. Maximum likelihood phylogenetic analysis of the internal transcribed spacer-rDNA sequence of Scedosporium dehoogii obtained from paddy field soil in Iran. Bootstrap values were calculated from 1000 replications. Lomentospora prolificans (CBS 116908) was used as the outgroup

This Iranian isolate was placed in the S. dehoogii clade in this phylogenetic analysis. The sequence of this strain was closely related to strains obtained from Chile (KT600015.1), Malaysia (OK576715.1), and China (MZ469293.1).

Antifungal susceptibility testing

Antifungal susceptibility testing was performed using broth microdilution for filamentous fungi according to the Clinical and Laboratory Standards Institute M38-A3 guideline [ 12 ]. The minimum inhibitory concentrations (MICs) and minimal effective concentrations (MECs) were detected after 72 h and 48 h, respectively. Paecilomyces variotii ATCC 22319 and Candida parapsilosis ATCC 22019 served as quality controls isolates.

The MIC/MEC values against amphotericin B, posaconazole, isavuconazole, voriconazole, itraconazole, anidulafungin, micafungin, and luliconazole were 4, 0.5, 4, 4, > 16, 0.032, 0.032, and 0.008 µg/mL, respectively. Among the established antifungal agents, luliconazole was the most active. In contrast, itraconazole was the least active agent against this strain.

Measurements of physicochemical soil parameters

Soil pH, ammonium (NH4+), and nitrate (NO3-) concentrations were measured at 7.89, 41.5 mg/kg, and 27.5 mg/kg, respectively, using soil test analysis as described previously [ 13 , 14 ].

Discussion

Understanding the ecological niches and natural habitats of Scedosporium species has usually depended on the sporadic isolation of these emergent fungi. Scedosporium species are ubiquitous fungi that can cause pathogenic diseases in humans and animals. In recent reports, several strains of S. dehoogii were isolated from sites with high levels of human activity, including playgrounds, public parks, industrial areas, riverbanks, or agricultural areas in different countries, such as France [ 6 ], Australia [ 15 ], Thailand [ 7 , 16 ], Chile [ 9 ], India [ 17 ], Mexico [ 18 ], Sudan [ 19 ], Taiwan [ 8 ], and Austria/The Netherlands [ 5 ].

In Iran, several human scedosporiosis have been reported [ 20 - 26 ]. These isolates have been identified based on the morphological and molecular methods that triggered illness through S. boydii, S. apiospermum, S. aurantiacum, and S. ellipsoideum, which are the most prevalent species described in the literature [ 20 - 26 ]. The current study reported the presence of S. dehoogii in paddy field soil in Iran for the first time. The primary morphological determination was confirmed by molecular methods, which is in agreement with the evidence formerly reported by other studies [ 27 ]. This finding is particularly noteworthy since this species is a potential human and animal pathogen and had not been previously reported in paddy field soil in Iran.

However, there is limited information on the in vitro antifungal susceptibility of this fungus. High MECs for echinocandins have been reported in previous investigations [ 28 , 29 ], which is inconsistent with the results of the present study. Based on the findings of the present research, luliconazole was the most active antifungal drug, which is in line with the results of another study [ 30 , 31 ]. However, some studies have reported that S. dehoogii is associated with high voriconazole and itraconazole MICs which is in agreement with the findings of this study [ 18 , 29 , 32 ].

Soil parameters, like pH and ammonium concentration, have demonstrated predictive usefulness for the isolation of the Scedosporium species in soils. Most Scedosporium culture-positive soil samples revealed a pH range of 6-8 [ 5 , 18 ]. It has been proven that Scedosporium species are strongly linked to environmental organic pollution brought on by animal and human activity [ 5 , 18 , 33 ]. This suggests a typical occurrence of Scedosporium species in areas rich in nutrients, fertilized agricultural soils, and human-dominated environments. Knowledge of the ecological niches and natural habitats of Scedosporium species is crucial for a better understanding of the dispersion of these fungi and the potential identification of an infection source.

Conclusion

Based on the result, molecular identification was essential for distinguishing the species of S. dehoogii. Remarkably, luliconazole has shown potent activity against this strain. However, more comprehensive studies are needed to assess the spectrum of Scedosporium species resources and natural niches in Iran.

Ethical approval

The Ethics Committee approved this research of the Mazandaran University of Medical Sciences (IR.MAZUMS.REC.1398.420).

Acknowledgments

The authors are grateful to the parasitology and mycology research center staff for their supportive help during the research process. This study was financially supported by a grant (no. 2928) from the School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Authors’ contribution

H.B. conceived and designed the study. J.Jav., I.H., and J.Jaf. contributed to the acquisition, analysis, and interpretation of data. Material preparation was performed by M.A. and H.B. J.Jav. drafted the manuscript. All authors provided critical revisions for important intellectual content and also read and approved the final manuscript.

Conflicts of interest

The authors declare no conflict of interest.

Financial disclosure

This study was financially supported by Mazan-daran University of Medical Sciences, Sari, Iran.

References

  1. Rougeron A, Giraud S, Alastruey-Izquierdo A, Cano-Lira J, Rainer J, Mouhajir A, et al. Ecology of Scedosporium species: present knowledge and future research. Mycopathologia. 2018; 183(1):185-200.
  2. Luplertlop N. Pseudallescheria/Scedosporium complex species: From saprobic to pathogenic fungus. J Mycol Med. 2018; 28(2):249-56.
  3. Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008; 21(1):157-97.
  4. Ramirez-Garcia A, Pellon A, Rementeria A, Buldain I, Barreto-Bergter E, Rollin-Pinheiro R, et al. Scedosporium and Lomentospora: an updated overview of underrated opportunists. Med Mycol. 2018; 56(1):102-25.
  5. Kaltseis J, Rainer J, De Hoog GS. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples. Med Mycol. 2009; 47(4):398-405.
  6. Rougeron A, Schuliar G, Leto J, Sitterle E, Landry D, Bougnoux ME, et al. Human-impacted areas of France are environmental reservoirs of the Pseudallescheria boydii/Scedosporium apiospermum species complex. Environ Microbiol. 2015; 17(4):1039-48.
  7. Luplertlop N, Muangkaew W, Pumeesat P, Suwanmanee S, Singkum P. Distribution of Scedosporium species in soil from areas with high human population density and tourist popularity in six geographic regions in Thailand. PLoS One. 2019; 14(1):e0210942.
  8. Huang YT, Fan YC, Hung TC, Chen CY, Sun PL. The high diversity of Scedosporium and Lomentospora species and their prevalence in human-disturbed areas in Taiwan. bioRxiv.
  9. Alvarez E, Sanhueza C. New record of Scedosporium dehoogii from Chile: Phylogeny and susceptibility profiles to classic and novel putative antifungal agents. Rev Iberoam Micol. 2016; 33(4):224-9.
  10. Pham T, Giraud S, Schuliar G, Rougeron A, Bouchara JP. Scedo-Select III: a new semi-selective culture medium for detection of the Scedosporium apiospermum species complex. Med Mycol. 2015; 53(5):512-9.
  11. Javidnia J, Ghotbi Z, Ghojoghi A, Solhjoo K, Alshahni MM, Jeddi SA, et al. Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study. Mycopathologia. 2022; 187(2-3):225-33.
  12. CLSI. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38–A3. Clinical and Laboratory Standards Institute Wayne, PA.
  13. Robinson WO. Method and procedure of soil analysis used in the division of soil chemistry and physics: US Department of Agriculture; 1939.
  14. Etheridge R, Pesti G, Foster E. A comparison of nitrogen values obtained utilizing the Kjeldahl nitrogen and Dumas combustion methodologies (Leco CNS 2000) on samples typical of an animal nutrition analytical laboratory. Anim Feed Sci Technol. 1998; 73(1-2):21-8.
  15. Harun A, Gilgado F, Chen SC, Meyer W. Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis. Med Mycol. 2010; 48(1):70-6.
  16. Luplertlop N, Pumeesat P, Muangkaew W, Wongsuk T, Alastruey-Izquierdo A. Environmental screening for the Scedosporium apiospermum species complex in public parks in Bangkok, Thailand. PLoS One. 2016; 11(7):e0159869.
  17. Sharma R, Kulkarni G, Sonawane MS, Shouche YS. New record of Scedosporium dehoogii from India. Mycotaxon. 2013; 124(1):239-45.
  18. Elizondo-Zertuche M, de J, Treviño-Rangel R, Robledo-Leal E, Luna-Rodríguez CE, Martínez-Fierro ML, Rodríguez-Sánchez IP, et al. Molecular identification and in vitro antifungal susceptibility of Scedosporium complex isolates from high-human-activity sites in Mexico. Mycologia. 2017; 109(6):874-81.
  19. Mhmoud NA. Molecular Identification of Pseudallescheria and Scedosporium Species complex from Soil in Sudan. Res Sq. 2022;1-20.
  20. Ghasemian R, Bandegani A, Kermani F, Faeli L, Roohi B, Yousefi-Abdolmaleki E, et al. Fatal pulmonary Scedosporium aurantiacum infection in a patient after near-drowning: A case report. Curr Med Mycol. 2021; 7(4):38-42.
  21. Hedayati MT, Tavakoli M, Maleki M, Heidari S, Mortezaee V, Gheisari M, et al. Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex. Microb Pathog. 2019; 129:168-75.
  22. Izadi A, Soleimani M, Dos Santos CO, Tehupeiory-Kooreman MC, Daie Ghazvini R, Hashemi SJ, et al. Fungal keratitis caused by Pseudallescheria boydii: clinical and mycological characteristics. J Ophthalmic Inflamm Infect. 2021; 11(1):1-5.
  23. Moghaddami M, Valikhani M. A case report of maduromycosis (Pseudallescheria boydii) infection treated with ketoconazole. Med J Islamic Rep Iran. 1989; 2(4):317-9.
  24. Asgari M, Alilou M. Mycetoma in Iran. The first report of eight cases with mycological studies. Ann Soc Belg Med Trop. 1972; 52(4):287-305.
  25. Moghaddami M, Kordbachae P. Report of thirteen cases of mycetoma. Med J Islamic Rep Iran. 1989; 3(3):183-6.
  26. Salehi E, Hedayati MT, Zoll J, Rafati H, Ghasemi M, Doroudinia A, et al. Discrimination of Aspergillosis, Mucor-mycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays. J Clin Microbiol. 2016; 54(11):2798-803.
  27. Gilgado F, Cano J, Gene J, Serena C, Guarro J. Different virulence of the species of the Pseudallescheria boydii complex. Med Mycol. 2009; 47(4):371-4.
  28. Gilgado F, Serena C, Cano J, Gene J, Guarro J. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother. 2006; 50(12):4211-3.
  29. Lackner M, de Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, et al. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother. 2012; 56(5):2635-42.
  30. Todokoro D, Suzuki T, Tamura T, Makimura K, Yamaguchi H, Inagaki K, et al. Efficacy of luliconazole against broad-range filamentous fungi including Fusarium solani species complex causing fungal keratitis. Cornea. 2019; 38(2):238-42.
  31. Maeda J, Koga H, Yuasa K, Neki D, Nanjoh Y, Inagaki K, et al. In vitro antifungal activity of luliconazole against nondermato-phytic moulds. Med Mycol. 2020; 58(5):703-6.
  32. Wiederhold NP, Lewis RE. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi. Med Mycol. 2009; 47(4):422-32.
  33. Guarro J, Kantarcioglu AS, Horré R, Luis Rodriguez-Tudela J, Cuenca Estrella M, Berenguer J, et al. Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Sabouraudia. 2006; 44(4):295-327.
Volume 8, Issue 4
December 2022
Pages 27-31
  • Receive Date: 04 November 2022
  • Revise Date: 04 January 2023
  • Accept Date: 06 January 2023
  • Publish Date: 01 December 2022